New pharmacists drawn to niche practice optionsCommunity pharmacy is still the biggest draw, but young practitioners appear to be searching for unique career opportunities Monoclonal antibody combination approved for mild/moderate COVID-19Health Canada grants interim authorization to Roche’s casirivimab and imdevimab. Overview of recent oral oncology drugs An overview of new oral targeted cancer therapies for community pharmacists The end: a hopeful chapter of life To ensure you receive the best care when you're unable to speak for yourself, creating an advance care plan is critical. We realized how important and essential this is during our clinical rotations. White House taps retailers to serve as drive-through testing sites Half a million tests to be available early next week, says Trump. College of Health Leaders announces six recipients of its 2019 National Awards Natural health products: How to assess the potential benefits and risks in patients with cancer Ocrevus receives conditional approval for use in early primary progressive MS Intravenous monoclonal antibody originally approved only for use in relapsing remitting multiple sclerosis (MS) Tax changes still leave provisions for the wealthy Kevzara: new SC biologic for moderate to severe RA Second interleukin-6 antagonist for rheumatoid arthritis reaches the Canadian market. First Previous 3 4 5 6 7 Next Last
